Thomas John Carroll

Thomas John Carroll

Auto-generated profile, based on publicly available information

Thomas John Carroll

University of Rochester, NY, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2023 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
TCThomas J. Carroll
Thomas J. Carroll
CDChristopher M. Dussik
Christopher M. Dussik
ZCZachary Clary
Zachary Clary
SHSamantha Hoffman
Samantha Hoffman
WHWarren Hammert
Warren Hammert
BMBilal Mahmood
Bilal Mahmood

14 January 2024 in Journal of Orthopaedics
Verified
Journal Article
Closed access
ZMZachary Morrisey
Zachary Morrisey
JCJordan Cruse
Jordan Cruse
MBMatthew Barra
Matthew Barra
TCThomas Carroll
Thomas Carroll
CDChristopher Drinkwater
Christopher Drinkwater

23 October 2023 in The Journal of Hand Surgery
Verified
Journal Article
Closed access
TCThomas John Carroll
Thomas John Carroll
ACAlexander Chirokikh
Alexander Chirokikh
JTJulie Thon
Julie Thon
CJCourtney Marie Cora Jones
Courtney Marie Cora Jones
ELEric Logigian
Eric Logigian
CKConstantinos Ketonis
Constantinos Ketonis

14 November 2023 in Journal of Orthopaedics
Verified
Journal Article
Closed access
ZMZachary Morrisey
Zachary Morrisey
TCThomas Carroll
Thomas Carroll
PCPatrick Castle
Patrick Castle
MBMina Botros
Mina Botros
DWDanielle Wilbur
Danielle Wilbur

27 December 2023 in Journal of Hand Surgery Global Online
Verified
Journal Article
Open access
TCThomas John Carroll
Thomas John Carroll
ADAkhil Dondapati
Akhil Dondapati
MMMichaela Malin
Michaela Malin
CKConstantinos Ketonis
Constantinos Ketonis
WHWarren Hammert
Warren Hammert
RGRonald Gonzalez
Ronald Gonzalez
Distal radius fractures (DRFs) indicated for operative intervention are most commonly treated with volar-locked plating (VLP); however, dorsal bridge plating (DBP) has been used as an alternative fixation method. The purpose of this study was to use a propensity score to match and compare the radiographic and clinical outcomes of patients undergoing isolated VLP or DBP for DRFs. We performed a retrospective, propensity score-matched analysis of patients undergoing isolated VLP or DBP treatment for isolated DRFs from 2015 to 2022 at a single level-1 trauma center. Patients were propensity score-matched by a total of eight demographic and comorbidity factors, AO Foundation/Orthopedic Trauma Association classification, and preoperative Patient-Reported Outcomes Measurement Information System (PROMIS) scores. Our primary outcomes included postoperative complications, wrist and forearm range of motion (ROM), grip strength, and radiographic measurements, including radial height, radial inclination, volar tilt, and articular step-off. Overall, 415 DBP and 2075 VLP were successfully propensity score-matched and included in this study. Grip strength and ROM measurements at the 6-month follow-up, including wrist flexion, wrist extension, forearm pronation, forearm supination, radial deviation, and ulnar deviation, were increased in the VLP compared with DBP (P < .05). Complication rates among both the groups were relatively low; however, the rates of malunion and nonunion were significantly higher among the DBP group (P < .05). Radial height, radial inclination, and articular step-off were improved in the VLP group compared with the DBP group (P < .05); however, volar tilt was similar between groups. PROMIS upper extremity and physical function were significantly higher among the VLP group (P < .05). No significant difference was noted in PROMIS pain interference between the groups. When compared with DBP, patients undergoing VLP are more likely to have improved clinical and radiographic outcomes. Although improvement in wrist and forearm ROM and radiographic parameters is statistically significant, it may not be clinically relevant. Therapeutic III.

10 October 2023 in Journal of Hand Surgery Global Online
Verified
Journal Article
Open access
TCThomas John Carroll
Thomas John Carroll
MBMina Botros
Mina Botros
RLRichard Lander
Richard Lander
SMSophia Moody
Sophia Moody
MRMegan L. Reitenbach
Megan L. Reitenbach
DWDanielle Wilbur
Danielle Wilbur
Perilunate fracture dislocation (PLFD) injuries are associated with the development of acute carpal tunnel syndrome (CTS). The purpose of our study was to identify the factors that increase the likelihood of developing CTS in patients with PLFD. Additionally, we attempted to classify patients who did not initially undergo carpal tunnel release (CTR) at the time of injury but eventually underwent CTR within the follow-up period. Patients presenting to a level-1 trauma center with isolated PLFDs (Mayfield III–IV) were retrospectively identified by using CPT and ICD-10 codes. Polytraumatized patients, those with a history of previous wrist trauma, or those with previous carpal tunnel symptoms or surgery were excluded. Outcomes of interest included the development of acute CTS, pre- and post-reduction changes in CTS symptoms, and associated hand and wrist fractures. Chi-square tests, Kruskal–Wallis tests, and multivariate logistic regression were used to examine the predictors of developing CTS after a PLFD. In total, 43 patients were included in the final cohort, with a mean age of 44 years, of which 77% were men. The most common fracture of the carpus included scaphoid fractures (9/43, 21%). The average time from presentation to reduction was 636 minutes. Acute CTS symptoms before reduction were present in 26% of the patients and increased post-reduction to 28%. No difference exists between the time to sedation and the presence of acute carpal tunnel symptoms (P >.05). During initial surgical intervention, 79% underwent CTR (27/34). Of the seven patients who did not initially undergo a CTR, 57% (4/7) required a CTR within the follow-up period. Reduction of PLFDs did not significantly improve the number of patients with acute CTS. More than 50% of the patients who did not undergo a CTR at the initial surgery required a CTR within the follow-up period. Prognostic III.